聚(N-异丙基丙烯酰胺-g-壳聚糖)微粒的制备及其药物缓释性

以三聚磷酸钠为离子交联剂制备壳聚糖颗粒(CS);以N,N1-亚甲基双丙烯酰胺为交联剂,由N-异丙基丙烯酰胺与CS接枝共聚合成了聚(N-异丙基丙烯酰胺-g-壳聚糖)微粒[P(NIPAM-g-CS)],其结构经IR和SEM表征.DSC测试结果显示,P(NIPAM-g-CS)具有温敏性,体积相转变温度33.51℃.P(NIPAM-g-CS)在中性条件下有良好的药物缓释性.     

聚氯乙烯-g-聚甲基丙烯酸-2-羟乙酯共聚物的合成和表征

聚氯乙烯 (ＰＶＣ)是常用医用高分子材料之一 ,可以制作储血袋、导液管、人工尿道等 .ＰＶＣ亲水性差 ,影响其生物相容性 .采用亲水性单体与ＰＶＣ接枝共聚是提高ＰＶＣ亲水性的重要方法[1] .Ｋｒｉｓｈｎａｎ等[2 ] 对Ｃｏ60 辐照下ＰＶＣ接枝Ｎ 乙烯基吡咯烷酮进行了研究 .Ｓｉｎｇｈ等[3～ 5] 采用辐照引发甲基丙烯酸在ＰＶＣ薄膜的接枝反应 ,对接枝动力学、接枝后薄膜表面形态、溶胀和抗凝血性等进行了研究 .Ｇｏｌｄｂｅｒｇ等[6] 采用辐照引发甲基丙烯酸2 羟乙酯 (ＨＥＭＡ)在ＰＶＣ薄膜上的接枝 .Ｌｅｅ等[7]采用溶液接枝共聚制备了…     

聚环氧乙烷-g-聚己内酯两亲性接枝共聚物的合成及药物释放行为

通过环氧丙醇(GL)与环氧乙烷(EO)的阴离子顺序开环聚合制备了水溶性嵌段共聚物PEO-b-PGL, 以PGL嵌段每个重复单元的侧羟基为引发点进一步引发ε-己内酯(CL)的开环聚合, 合成了结构规整的以聚环氧乙烷(PEO)为主链的两亲性接枝共聚物(PEO-b-PGL-g-PCL). 研究了PEO-b-PGL-g-PCL在水相中的自组装行为, 采用稳态荧光探针法测定了胶束的临界胶束浓度(cmc). 以疏水性药物阿霉素(DOX)为模型药物, 研究了两亲性接枝共聚物的化学组成对药物的扩散释放以及降解释放行为的影响.     

聚甘油酸-g-胆固醇胶束的制备及药物释放性能研究

以甘油酸为单体,通过本体缩聚制备了水溶性生物降解高分子聚甘油酸,利用聚甘油酸侧基上的羟基固定生物相容性好的疏水性分子胆固醇,通过亲疏水作用自组装形成胶束.以形成的胶束作为载体负载抗肿瘤药物阿霉素,研究了药物的体外释放行为.将肝癌细胞HepG2与载药胶束共培养研究其体外抗肿瘤效果.研究结果表明,聚甘油酸-g-胆固醇共聚物...     

均匀设计法在壳聚糖-g-丙烯腈制备上的应用

接枝共聚;均匀设计法在壳聚糖-g-丙烯腈制备上的应用     

壳聚糖-g-β-环糊精的制备与表征

N-(3-氯-2-羟基)丙基壳聚糖与β环糊精在碱性条件下反应制得了一种新型壳聚糖-g-β-环糊精(3),其结构经UVVis,IR和XRD表征。3的β-环糊精表观固载量为25.48μmol·g-1。     

壳聚糖-g-水杨酸的合成

合成了壳聚糖-g-水杨酸,用1^H NMR,IR和热重分析等对结构进行了表征。接枝反应的最佳条件为：壳聚糖12．5mmol,n（水杨酸）：n（壳聚糖）=0．75,于55℃～65℃反应1h,水杨酸接枝率为20％。     

壳聚糖-聚丙烯酸复合水凝胶的药物控制释放行为

以壳聚糖(Cs)和丙烯酸(AA)为原料,利用自由基聚合法制备了具有孔洞结构的复合水凝胶Cs-PAA,并研究了AA的量、交联剂的量、聚合温度和AA的中和度对水凝胶溶胀度的影响以及复合水凝胶对烟酸的控制释放。 结果表明,Cs-PAA复合水凝胶具有良好的pH值、离子强度敏感性,且溶胀度最高达1228 g/g,其在pH=686的缓冲溶液中的烟酸累积释放率明显大于其在pH=1.80的缓冲溶液,因此Cs-PAA水凝胶可作为肠口服药物的载体。     

药物在pH敏感聚甲基丙烯酸-poloxamer水凝胶中的扩散行为

平衡溶胀率;药物扩散;药物在pH敏感聚甲基丙烯酸-poloxamer水凝胶中的扩散行为     

核壳型聚（丙烯酸丁酯/甲基丙烯酸十二酯）乳液的制备及表征

丙烯酸丁酯;甲基丙烯酸十二酯;核壳结构;制备     

磁性壳聚糖微球的制备、表征及其靶向给药研究

磁性微球;阿司匹林;磁性壳聚糖微球的制备、表征及其靶向给药研究     

壳聚糖-两性聚氨酯接枝共聚物的制备

利用壳聚糖大分子链上的－OH和－NH2基团与两性聚氨酯预聚体的端－NCO基团反应，把两性聚氨酯链接枝到壳聚糖分子链上，为聚电解质及纳米胶体粒子间的组装，复合性质的研究提供模型化合物，红外光谱，热分析方法初步研究表明，采用上述方法能够制备出APU－壳聚糖接枝共聚物，但产物是壳聚糖与接枝共聚物的混合物，研究发现，这种接枝共聚物在盐酸水溶液中呈胶束形态，而且具有独特的流变性。     

（2-羟基-3-丁氧基）丙基-羟丙基壳聚糖/聚乙二醇互穿网络凝胶的制备及其释药作用

将壳聚糖改性为（2-羟基-3-丁氧基）丙基 羟丙基壳聚糖（2-H-3-B-P-HPCS）,并以（2-羟基-3-丁氧基）丙基-羟丙基壳聚糖和聚乙二醇（PEG）为原料制备（2-羟基-3-丁氧基）丙基-羟丙基壳聚糖/聚乙二醇互穿网络凝胶,研究了（2-羟基-3-丁氧基）丙基-羟丙基壳聚糖浓度、聚乙二醇的用量、交联剂戊二醛用量、反应温度对该凝胶溶胀性能的影响。 通过红外光谱分析和扫描电子显微镜的方法比较了壳聚糖、（2-羟基-3-丁氧基）丙基-羟丙基壳聚糖和（2-羟基-3-丁氧基）丙基-羟丙基壳聚糖/聚乙二醇互穿网络凝胶结构和形态上的不同。 以阿昔洛韦为模型药物研究了其释药性能。 结果表明,该凝胶均具有良好的溶胀性、pH敏感性和药物缓释作用,有望用作新型的药物载体。     

Graft copolymerization of methacrylic acid and acrylamide onto acrylonitrile-butadiene-styrene terpolymer by photoinduced hydroperoxide

Graft copolymerization of methacrylic acid (MAA) or acrylamide (AM) from an aqueous solution onto acrylonitrile-butadiene-styrene terpolymer (ABS) was initiated by the thermal decomposition of polymeric hydroperoxides, which are formed upon UV irradiationof ABS, which contains anthracene. Diffusion of anthracene at room temperature from a methanolic solution into ABS was affected by the acrylonitrile content ofABS.The graft yield was independent on the concentration of anthracene in the wide range of 0.03 X 10^-3 to 14.29 X 10^?3 mol/L in ABS. The graft polymerization reaction does not occur below 100°C.The effect of other variables, such as time of irradiation, intensity of UV, reaction time, and concentration of monomer in aqueous solution, on the amount of monomer grafted to ABS were also investigated.The contact angle significantly decreases upon grafting, indicating that the graft layer is on the surface of the polymer. © 1995 John Wiley & Sons, Inc.     

聚(乳酸-羟基乙酸)共聚物涂层的释药性能

以乙酸乙酯为溶剂,配制聚(乳酸-羟基乙酸)共聚物(PLGA)雷帕霉素溶液,利用滴涂法在316L不锈钢表面制备PLGA载药涂层。于37℃磷酸盐缓冲液(PBS)中进行体外动态药物释放,并用紫外-可见分光光度计测定药物释放量。结果表明:PLGA涂层中PLGA分子量越小,羟基乙酸(GA)含量越高,药物释放越快;药物释放量与滴涂量呈线性关系,药物释放率与滴涂量的倒数呈线性关系;涂层中药物含量增加,其释放量也随之增加,而药物释放率先增加后降低。     

Poly(p‐phenylene) with Poly(ethylene glycol) Chains and Amino Groups as a Functional Platform for Controlled Drug Release and Radiotherapy

Conventional cancer treatments such as chemotherapy, radiotherapy, or combination of these two result in side effects, which lower the quality of life of the patients. To overcome problems with these methods, altering the drug properties by conjugating them to carrier polymers has emerged. Such polymeric carriers also hold the potential to make tumor cells more sensitive to radiation therapy. Herein, poly(p‐phenylene) (PPP) polymer with poly(ethylene glycol) (PEG) chains and primary amino groups (PPP‐NH₂‐g‐PEG) is synthesized and conjugated with anticancer drug Doxorubicin (DOX). pH dependent drug release experiments are performed at pH 5.3 and pH 7.4, respectively. Cell viability studies on human cervix adenocarcinoma cells show that lower doses of DOX inhibit cell proliferation when conjugated with nontoxic doses of PPP‐NH₂‐g‐PEG polymer. Additionally, PPP‐NH₂‐g‐PEG/Cys/DOX bioconjugate significantly increases radiosensitive properties of DOX. It is possible to use lower doses of DOX when conjugated to PPP‐NH₂‐g‐PEG in combination with radiotherapy.

     

PMAA纳米水凝胶的水相制备

利用表面活性剂间的疏水作用以及表面活性剂与单体间的氢键作用,促使甲基丙烯酸(MAA)单体在原位生成的聚甲基丙烯酸甲酯(PMMA)种子乳胶表面的选择性聚合,实现了PMAA纳米水凝胶的水相"绿色"制备。利用动态光散射、傅里叶红外光谱、透射电子显微镜表征了PMAA纳米水凝胶的尺寸、组成、形貌和pH响应性。研究了聚氧乙烯失水山梨醇单月桂酸酯(吐温20)的用量、N,N’-亚甲基双丙烯酰胺(MBA)的用量、MAA的用量和加入方式、十二烷基硫酸钠(SDS)的补加速率等对PMAA纳米水凝胶的尺寸和溶胀性能的影响。结果表明:PMAA纳米水凝胶为核-壳结构;随着MBA用量的减小、吐温20用量的增加、MAA用量的增加,PMAA纳米水凝胶的尺寸和溶胀比均增大;当采用半连续加入MAA时,PMAA纳米水凝胶的尺寸和溶胀比变小;当SDS的补加时间由60min延长到100min时,PMAA纳米水凝胶的尺寸逐渐变小。PMAA纳米水凝胶具有良好的pH响应性,当介质的pH从1增加到6时,其流体力学体积扩张了64倍。     

Versatile Pectin Grafted Poly (N-isopropylacrylamide); Modulated Targeted Drug Release

This study describes synthesis and optimization of pectin grafted poly(N-isopropylacrylamide) hydrogels as vehicles for colon-targeted theophylline model drug release. The gels were prepared in the presence of N, N′–methylenebisacrylamide (MBAA) crosslinker and ceric ammonium nitrate (CAN) initiator under N₂ atmosphere. Optimum conditions, in terms of percent of grafting (%G), were determined as follows: pectin = 1.0 g, [NIPAAm] = 26.51 mM, [MBAA] = 0.65 mM, [CAN] = 0.073 mM, polymerization temperature = 30°C and time = 4.0 h. Hydrogels were characterized by FTIR, TGA, DSC, XRD and SEM. The formed hydrogel did not have a thermo-sensitivity behavior. The in vitro percent drug release was studied in terms of different percent of grafting and different polymerization temperatures under two pH values namely 5.5 and 7.4. Conclusively, the optimum colon-targeted vehicle properties that provide the least drug release at pH5.5 and the most drug release at pH7.4 were as follows: [NIPAAm] = 26.51 mM and [MBAA] = 0.56 mM, polymerization temperature = 30°C and %G = 55.5.     

新型羧甲基壳聚糖水凝胶流变性能,药物释放及细胞相容性研究

羧甲基壳聚糖含有丰富的羧基和氨基, 通过1-乙基-(3-二甲基氨基丙基)碳二亚胺盐酸盐(EDC)和N-羟基琥珀酰亚胺(NHS)共催化交联羧甲基壳聚糖形成新型水凝胶. 调节EDC/NHS用量, 制备不同交联度的羧甲基壳聚糖水凝胶(CMCS hydrogels). 研究水凝胶的流变行为, 结果表明, 高交联度的水凝胶具有较好的弹性形变能力, 较高的储存模量, 这是因为随着交联度的升高, 羧甲基壳聚糖水凝胶化学交联网络结构趋于完善. 以胸腺五肽(TP-5)为模型药物, 初步评价CMCS水凝胶药物释放行为, 结果表明水凝胶交联度越高, 胸腺五肽释放速度越慢. MTT法初步评价了水凝胶细胞毒性, 细胞形态和细胞相对增值速率, 结果表明水凝胶毒性很低. 由此可见, 水凝胶具有良好的生物相容性, 在药物缓释和组织工程领域具有广阔的应用前景.     

Synthesis and Characterization of Chitosan Grafted Oligo(L‐lactic acid)

Chitosan grafted oligo(L ‐lactic acid) copolymers with different length of side chain were prepared through the reaction of terminal aldehyde group of oligo(L ‐lactic acid) (OLLA) and amino groups of chitosan. The mean molecular mass of the grafting OLLA chain was ca. 600 ～ 5 000. The graft copolymers are soluble in DMSO, DMF and acetic acid. The synthesis method and structure described here provide chitosan‐g‐OLLA copolymers with broad applicability.

Structure of chitosan‐g‐oligo(L ‐lactic acid).